Biommune Technologies In (IMU.CA) Stock Overview
Canada - TSX-V:IMU -
IMU.CA Key Statistics, Chart & Performance
The current stock price of IMU.CA is 0.44 null. In the past month the price decreased by -3.3%. In the past year, price increased by 25.71%.
About IMU.CA
Company Profile
bioMmune Technologies Inc is a biopharmaceutical company. The Company is engaged in the research and development of products for the treatment of cancers, and for improvement of the immune system.
Company Info
Biommune Technologies In
400 Burrard Street
Vancouver BC V6C 3A6
CEO: Patrick W. Gray
Phone: +1 604 880-7250
Biommune Technologies In / IMU.CA FAQ
What is the stock price of Biommune Technologies In today?
The current stock price of IMU.CA is 0.44 null. The price decreased by -8.33% in the last trading session.
What is the ticker symbol for Biommune Technologies In stock?
The exchange symbol of Biommune Technologies In is IMU and it is listed on the TSX Venture Exchange exchange.
On which exchange is IMU.CA stock listed?
IMU.CA stock is listed on the TSX Venture Exchange exchange.
What is Biommune Technologies In worth?
Biommune Technologies In (IMU.CA) has a market capitalization of 14.32M null. This makes IMU.CA a Nano Cap stock.
What are the support and resistance levels for Biommune Technologies In (IMU.CA) stock?
Biommune Technologies In (IMU.CA) has a support level at 0.43 and a resistance level at 0.44. Check the full technical report for a detailed analysis of IMU.CA support and resistance levels.
Should I buy Biommune Technologies In (IMU.CA) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of IMU.CA, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of IMU.CA, evaluating the profitability, health, valuation and growth aspects
- Biommune Technologies In (IMU.CA) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- Biommune Technologies In (IMU.CA) Sales and EPS estimates to see what analysts future expectations are.
- Biommune Technologies In (IMU.CA) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- Biommune Technologies In (IMU.CA) Insider and Institutional Ownership to learn about the owners and their transactions.
- Biommune Technologies In (IMU.CA) Stock Chart to make your own analysis
- Biommune Technologies In (IMU.CA) Latest news and press-releases to stay up to date.
Does Biommune Technologies In (IMU.CA) stock pay dividends?
IMU.CA does not pay a dividend.
What is the Price/Earnings (PE) ratio of Biommune Technologies In (IMU.CA)?
Biommune Technologies In (IMU.CA) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.05).
IMU.CA Technical Analysis
IMU.CA Financial Highlights
Over the last trailing twelve months IMU.CA reported a non-GAAP Earnings per Share(EPS) of -0.05.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | N/A | ||
| ROE | N/A | ||
| Debt/Equity | N/A |